Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-H Peter

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
Experimental and Clinical Immunogenetics|January 1, 1991
Immunoglobulin allotypes in systemic lupus erythematosus--results of a central European multicenter study. SLE Study GroupK Hartung, R Coldewey, E Röther, et al.
Rheumatology International|May 30, 1998
Diagnosis of idiopathic myositis: value of 99mtechnetium pyrophosphate muscle scintigraphy and magnetic resonance imaging in targeted muscle biopsyJ von Kempis, P Kalden, J Gutfleisch, et al.
European Journal of Nuclear Medicine|July 1, 1997
Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography studyA Otte, S M Weiner, H H Peter, et al.
Rheumatology (Oxford, England)|November 21, 2000
Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulinM Hundt, K Manger, T Dörner, et al.
International Journal of Clinical Pharmacology Research|November 16, 2001
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patientsL Färber, T H Stratz, W Brückle, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2011
Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapyS Jolles, E Bernatowska, J de Gracia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patientsW K Aicher, A H Heer, A Trabandt, et al.
Gynecologic Oncology|September 1, 1975
Radioprotection of the digestive tract by intravenous infusion of vasopressinG J Juillard, H H Peter, T H Weisenburger, et al.
The Journal of Clinical Investigation|October 1, 1992
Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter studyK Hartung, M P Baur, R Coldewey, et al.
The Journal of Rheumatology|November 28, 2000
IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosusT Witte, T Matthias, F C Arnett, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
Experimental and Clinical Immunogenetics|January 1, 1991
Immunoglobulin allotypes in systemic lupus erythematosus--results of a central European multicenter study. SLE Study GroupK Hartung, R Coldewey, E Röther, et al.
Rheumatology International|May 30, 1998
Diagnosis of idiopathic myositis: value of 99mtechnetium pyrophosphate muscle scintigraphy and magnetic resonance imaging in targeted muscle biopsyJ von Kempis, P Kalden, J Gutfleisch, et al.
European Journal of Nuclear Medicine|July 1, 1997
Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography studyA Otte, S M Weiner, H H Peter, et al.
Rheumatology (Oxford, England)|November 21, 2000
Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulinM Hundt, K Manger, T Dörner, et al.
International Journal of Clinical Pharmacology Research|November 16, 2001
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patientsL Färber, T H Stratz, W Brückle, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2011
Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapyS Jolles, E Bernatowska, J de Gracia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patientsW K Aicher, A H Heer, A Trabandt, et al.
Gynecologic Oncology|September 1, 1975
Radioprotection of the digestive tract by intravenous infusion of vasopressinG J Juillard, H H Peter, T H Weisenburger, et al.
The Journal of Clinical Investigation|October 1, 1992
Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter studyK Hartung, M P Baur, R Coldewey, et al.
The Journal of Rheumatology|November 28, 2000
IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosusT Witte, T Matthias, F C Arnett, et al.
Pageof 37